Patrick James Orme

Array ( [id] => 142266 [patent_doc_number] => 07687617 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-30 [patent_title] => 'Oligonucleotides with alternating segments of locked and non-locked nucleotides' [patent_app_type] => utility [patent_app_number] => 10/717434 [patent_app_country] => US [patent_app_date] => 2003-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 24 [patent_no_of_words] => 18978 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/687/07687617.pdf [firstpage_image] =>[orig_patent_app_number] => 10717434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5894792 [patent_doc_number] => 20060003331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Isolation of antisense oligonucleotides' [patent_app_type] => utility [patent_app_number] => 10/535728 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5612 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003331.pdf [firstpage_image] =>[orig_patent_app_number] => 10535728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 513750 [patent_doc_number] => 07192708 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-20 [patent_title] => 'Nucleic acid enzyme biosensors for ions' [patent_app_type] => utility [patent_app_number] => 10/702676 [patent_app_country] => US [patent_app_date] => 2003-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 21 [patent_no_of_words] => 14340 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/192/07192708.pdf [firstpage_image] =>[orig_patent_app_number] => 10702676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7343858 [patent_doc_number] => 20040191904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Antisense modulation of src-c expression' [patent_app_type] => new [patent_app_number] => 10/476962 [patent_app_country] => US [patent_app_date] => 2003-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26921 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20040191904.pdf [firstpage_image] =>[orig_patent_app_number] => 10476962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7149603 [patent_doc_number] => 20040171030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Oligomeric compounds having modified bases for binding to cytosine and uracil or thymine and their use in gene modulation' [patent_app_type] => new [patent_app_number] => 10/700920 [patent_app_country] => US [patent_app_date] => 2003-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33603 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171030.pdf [firstpage_image] =>[orig_patent_app_number] => 10700920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7287153 [patent_doc_number] => 20040147022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => '2\'-methoxy substituted oligomeric compounds and compositions for use in gene modulations' [patent_app_type] => new [patent_app_number] => 10/701264 [patent_app_country] => US [patent_app_date] => 2003-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34794 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20040147022.pdf [firstpage_image] =>[orig_patent_app_number] => 10701264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7447080 [patent_doc_number] => 20040186071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Antisense modulation of CD40 expression' [patent_app_type] => new [patent_app_number] => 10/698689 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29644 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20040186071.pdf [firstpage_image] =>[orig_patent_app_number] => 10698689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 281822 [patent_doc_number] => 07553822 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-30 [patent_title] => 'Compositions and methods for inhibiting translation of a Mect1-MAML2 chimeric gene' [patent_app_type] => utility [patent_app_number] => 10/698070 [patent_app_country] => US [patent_app_date] => 2003-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 1 [patent_no_of_words] => 7598 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/553/07553822.pdf [firstpage_image] =>[orig_patent_app_number] => 10698070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7166176 [patent_doc_number] => 20040076973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Antisense modulation of ubiquitin protein ligase expression' [patent_app_type] => new [patent_app_number] => 10/363828 [patent_app_country] => US [patent_app_date] => 2003-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26285 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20040076973.pdf [firstpage_image] =>[orig_patent_app_number] => 10363828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7304308 [patent_doc_number] => 20040115716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Methods of obtaining active antisense compounds' [patent_app_type] => new [patent_app_number] => 10/686317 [patent_app_country] => US [patent_app_date] => 2003-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10242 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115716.pdf [firstpage_image] =>[orig_patent_app_number] => 10686317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7334663 [patent_doc_number] => 20040132067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex' [patent_app_type] => new [patent_app_number] => 10/681822 [patent_app_country] => US [patent_app_date] => 2003-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 21181 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132067.pdf [firstpage_image] =>[orig_patent_app_number] => 10681822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7252217 [patent_doc_number] => 20050074819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Screening method of drug for treatment of neuropathic pain' [patent_app_type] => utility [patent_app_number] => 10/676289 [patent_app_country] => US [patent_app_date] => 2003-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12383 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20050074819.pdf [firstpage_image] =>[orig_patent_app_number] => 10676289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7290882 [patent_doc_number] => 20040110713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Antisense modulation of phospholipid scramblase 4 expression' [patent_app_type] => new [patent_app_number] => 10/673523 [patent_app_country] => US [patent_app_date] => 2003-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27124 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110713.pdf [firstpage_image] =>[orig_patent_app_number] => 10673523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7470868 [patent_doc_number] => 20040096884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Use of prothymosin in the diagnosis and treatment of endometriosis' [patent_app_type] => new [patent_app_number] => 10/654592 [patent_app_country] => US [patent_app_date] => 2003-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17014 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20040096884.pdf [firstpage_image] =>[orig_patent_app_number] => 10654592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 64362 [patent_doc_number] => 07759478 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-07-20 [patent_title] => 'Bioinformatically detectable viral regulatory genes' [patent_app_type] => utility [patent_app_number] => 10/604984 [patent_app_country] => US [patent_app_date] => 2003-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 30 [patent_no_of_words] => 16628 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/759/07759478.pdf [firstpage_image] =>[orig_patent_app_number] => 10604984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 133275 [patent_doc_number] => 07696334 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-04-13 [patent_title] => 'Bioinformatically detectable human herpesvirus 5 regulatory gene' [patent_app_type] => utility [patent_app_number] => 10/604942 [patent_app_country] => US [patent_app_date] => 2003-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 31 [patent_no_of_words] => 12899 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/696/07696334.pdf [firstpage_image] =>[orig_patent_app_number] => 10604942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7467869 [patent_doc_number] => 20040053874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Antisense modulation of clusterin expression' [patent_app_type] => new [patent_app_number] => 10/380124 [patent_app_country] => US [patent_app_date] => 2003-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23996 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053874.pdf [firstpage_image] =>[orig_patent_app_number] => 10380124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7386748 [patent_doc_number] => 20040029824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Antisense modulation of glioma-associated oncogen-1 expression' [patent_app_type] => new [patent_app_number] => 10/380126 [patent_app_country] => US [patent_app_date] => 2003-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24620 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029824.pdf [firstpage_image] =>[orig_patent_app_number] => 10380126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7206823 [patent_doc_number] => 20040087536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Antisense modulation of KOX 1 expression' [patent_app_type] => new [patent_app_number] => 10/643432 [patent_app_country] => US [patent_app_date] => 2003-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31588 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087536.pdf [firstpage_image] =>[orig_patent_app_number] => 10643432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7425298 [patent_doc_number] => 20040161417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Method of enhancing CD4+ T cell responses' [patent_app_type] => new [patent_app_number] => 10/641316 [patent_app_country] => US [patent_app_date] => 2003-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8489 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20040161417.pdf [firstpage_image] =>[orig_patent_app_number] => 10641316 [rel_patent_id] =>[rel_patent_doc_number] =>)